Roll Up Your Sleeves Folks: 271 New Vaccines in Big Pharma’s Pipeline
advertisement - learn more
PhRMA (the Pharmaceutical
Research and Manufacturers of America), the pharmaceutical industry’s
trade association and powerful lobbying group, says that
“today, more than 7,000 medicines are in development globally, all of which have the potential to help patients in the United States and around the world. According to another data source, there are 3,400 medicines in development today just in the United States, an increase of 40 percent since 2005.” (http://phrma.org/pipeline#sthash.TnxVihsT.dpuf)
PhRMA also says that today
“the 271 vaccines in development span a wide array of diseases, and employ exciting new scientific strategies and technologies. These potential vaccines – all in human clinical trials or under review by the Food and Drug Administration (FDA) – include 137 for infectious diseases, 99 for cancer, 15 for allergies and 10 for neurological disorders.” (http://phrma.org/press-release-medicines-in-development-vaccines#sthash.rI4cQ6Tg.dpuf)
Whenever the FDA signals that it is ready to grant marketing approval for a new vaccine or
drug, the first step for the pharmaceutical company’s marketing
department is to promote an “educational” advertising campaign designed
to instill fear in parents (and their pediatricians) about the horrible
illnesses (albeit previously unknown, benign or rare) that even us
doctors hadn’t yet recognized as being significant up until recently,
most of us physicians have gone along with the fear-mongering that makes
our practices busier while it also makes billions of dollars in profits
for some unworthy CEO or Wall Street investment banker, hedge fund
manager or mutual fund investor – all at the expense of America’s
precious and vulnerable children who are at high risk of being sickened
along the way.
advertisement - learn more
The TV commercials, medical
journal articles and drug representatives will be trying to educate us
about a new, unaffordable vaccine that will somehow be squeezed into an
already crowded and potentially deadly group of shots that America’s
already at-risk-of-vaccine-injuries infants will now be receiving at their next well-child (perhaps soon to become chronically ill).check-up.
Recognizing this, and so
as not to overload the already over-loaded well-child inoculation
schedule, perhaps he CDC (the Big Pharma-subsidized and vaccine
cheerleader Centers for Disease Control and Prevention) will be adding
shots to the in-hospital and irrational Hepatitis B shot that
it recommends be given on day one – when vulnerable mothers are too
exhausted and emotionally confused to give truly informed consent.
Many state legislatures
are, as we speak, considering (or have already passed laws)
criminalizing the previously legal parental right of refusing
vaccinations on the basis of religious or philosophical beliefs. That is
happening right now in Wisconsin’s Republican-dominated legislature,
Minnesota’s split GOP/DFL legislature, and California’s Democratic
Party-dominated legislature – where it is already signed into law by
Democrat Jerry Brown. These poorly informed – and heavily bribed
politicians don’t realize that their legislative efforts will be blindly
forcing unsuspecting patients to submit to every new blockbuster
vaccine that successfully emerges from the pipeline. Talk about making
decisions on the basis of partial information or propaganda from
sociopathic corporate entities! Attention, Senators Al Franken, Amy
Klobuchar and other assorted legislators. Are you listening to the real
science or to the corrupted, pseudoscience of Big Pharma?
Below is a list of 146 new
vaccines that were in the pipeline as of 2010. The list, PhRMA proudly
tells us, is now up to 271 new vaccines as of 2013. For a full listing
of these vaccine trials, go to: http://phrma.org/sites/default/files/pdf/infectiousdiseases2010%20%281%29.pdf
For parents whose infants’
brains and bodies are immunologically and developmentally immature, be
aware that your children may be forced to suffer untested-for and
therefore unacknowledged long term neurological, autoimmune and chronic
illness adverse effects. Parents need to be aware that if their infant
dies, is sickened or is made chronically ill by vaccine ingredients,
they, as protective parents, will be forbidden to sue the guilty drug
company (or the doctor that administered them) for appropriate damages.
Parents and grandparents of children need to be aware of the fact that many of these new vaccines will be containing contaminants (such
as unfilterable viral particles, bacterial particles, monkey kidney
cell fragments, human fetal cells, squalene (in anthrax and some
experimental swine flu vaccines), peanut oil (a likely cause of the
epidemic of peanut allergies), formaldehyde and even foreign DNA
fragments) as well as known neurotoxic additives such as formaldehyde
and aluminum (and perhaps even mercury), all of which are known genetic
toxins and known causes of (sometimes subtle and sometimes
not-so-subtle – but always preventable) brain damage, vaccine-induced epilepsy,
autoimmune disorders, the so-called, but erroneously labeled “shaken
baby syndrome” (now increasingly understood to represent a
vaccine-induced encephalitis), SIDS (sudden infant death syndrome),
dementia, autism spectrum disorders, mitochondrial toxicity, damage to the brain’s microglial and astroglial cells (the brain’s immune system), etc.
NOTE: Much of the information in this column is derived from easily accessible books and websites, including Make an Informed Vaccine Decision for the Health of Your Child by Mayer Eisenstein, MD, JD, MPH; The Sanctity of Human Blood: Vaccination is Not Immunization, by Tim O’Shea, DC; Screening Sandy Hook, Causes and Consequences by
Deanna Spingola (an online e-book); the writings and lectures of
Russell Blaylock, MD; Immunologist J. Barthelow Classen, MD; Harold E
Buttram, MD, Dr Sherri Tenpenny, Dr Suzanne Humphries, Dr Kenneth
Stoller, Dr Andrew Wakefield, Dr Mark Geier, and Dr Joseph Mercola, and
the following two articles: http://www.vaccines.net/vaccine-induced-immune-overload.pdf. http://www.globalresearch.ca/vaccine-induced-immune-overload-and-the-epidemic-of-chronic-autoimmune-childhood-disease/5431013.
A List of 146 of the 271 Vaccines in Big Pharma’s Developmental Pipeline (as of 2010)
(NOTE: The corporations that have the largest financial interest in the success of the trials is listed in bold letters.)
sanofi pasteur prevention of Clostridium difficile
ACE BioSciences prevention of traveler’s diarrhea caused by Campylobacter jejuni
ACE BioSciences prevention of traveler’s diarrhea caused by Escherichia coli
sanofi pasteur diphtheria, tetanus, pertussis Phase III DTP vaccine
Aeras Global tuberculosis
Novartis Vaccines prevention of influenza A infection (H5N1 subtype)
Antigenics treatment of herpes simplex virus
BioSante Pharmaceuticals anthrax Phase I/II vaccine
Intercell USA anthrax
KaloBios Pharmaceuticals Pseudomonas aeruginosa infections
Aduro BioTech treatment of hepatitis C
Emergent BioSolutions anthrax vaccine
AlphaVax prevention of influenza virus infections in the elderly
DynPort Vaccine botulism vaccine
Inviragen Chikungunya virus vaccine
Celldex Therapeutics cholera vaccine (live attenuated)
ChronTech Pharma hepatitis C (DNA vaccine)
Virionics prevention and treatment of hepatitis C
Vical prevention of cytomegalovirus (DNA vaccine)
AlphaVax prevention of cytomegalovirus infections
Hawaii Biotech prevention of dengue fever
GlaxoSmithKline prevention of dengue fever (tetravalent)
Acambis mild to severe dengue fever
sanofi pasteur DTP-Hep B
sanofi pasteur diphtheria, tetanus, pertussis, polio, hepatitis B, polio, Hib
Dynavax treatment of hepatitis B
Crucell prevention of Ebola virus infections
Vical prevention of Ebola virus infections
GenPhar Ebola virus vaccine
GlaxoSmithKline prevention of infectious mononucleosis (Epstein-Barr virus)
BioSolutions Escherichia coli infections
Celldex Therapeutics prevention of cholera, Escherichia coli infections
Protein Sciences prevention of influenza virus infections in adults and children
sanofi pasteur influenza virus infections (new mass production method)
sanofi pasteur prevention of influenza virus (intradermal micro-injection)
Protein Sciences influenza virus infections
GlaxoSmithKline rotavirus infections in infants
GlaxoSmithKline prevention of cytomegalovirus (recombinant vaccine)
GlaxoSmithKline influenza virus (trivalent, thimerosal-free) for children ages 3-17
GlaxoSmithKline prevention of influenza virus
GlaxoSmithKline prevention of Streptococcus pneumoniae
GlaxoSmithKline prevention
of diphtheria, tetanus, pertussis, Haemophilus infections, hepatitis B,
meningococcal group C infections, poliomyelitis (infants)
GlaxoSmithKline prevention of Haemophilus and pneumococcal infections
GlaxoSmithKline prevention of Haemophilus and pneumococcal infections
GlaxoSmithKline prevention of influenza virus infection in children
GlaxoSmithKline prevention of influenza A virus (H1N1 subtype) for children and infants
GlaxoSmithKline staphylococcal infections
MedImmune influenza A virus (H5N1 subtype) intranasal
Novavax prevention of influenza A virus infection
Hawaii Biotech prevention of West Nile virus infection
Novartis Vaccines helicobacter pylori
Pfizer hepatitis B (DNA)
Emergent BioSolutions hepatitis B
GenPhar hepatitis B
Novartis Vaccines treatment of hepatitis C
GlaxoSmithKline hepatitis E (recombinant)
Dynavax prevention of hepatitis B
Pfizer treatment of herpes simplex virus infections (DNA vaccine)
AuRx prevention and treatment of herpes simplex virus infections
sanofi pasteur diphtheria, tetanus, pertussis, hepatitis B, polio, Hib
Intercell prevention of influenza virus seasonal influenza
Novartis Vaccines prevention of herpes simplex virus infections
Acambis prevention of encephalitis virus
Bavarian Nordic smallpox vaccine
sanofi pasteur influenza A virus (H1N1 subtype) in adolescents, children and infants
CSL Behring prevention of influenza A virus (H1N1 subtype) for the elderly
Baxter Healthcare prevention of influenza A virus (H1N1 subtype)
Vical prevention of influenza A virus (DNA – H1N1 subtype)
Baxter Healthcare prevention of influenza A virus (H5N1 subtype)
DynPort Vaccine influenza virus
Antigen Express influenza virus infections H5N1 vaccine
Novavax prevention of influenza virus (particle vaccine)
Dynavax prevention of influenza virus infections
Vaxin influenza virus infections (intranasal)
Abbott Laboratories prevention of influenza virus (cell culture-derived)
Intercell prevention of Japanese encephalitis in children
Novartis Vaccines malaria vaccine (U.S. Naval Medical Research Center)
Vical malaria vaccine
BioSante Pharmaceuticals prevention of malaria (U.S. Naval Medical Research Center)
GenVec malaria vaccine (U.S. Naval Medical Research Center)
Crucell malaria vaccine
Sanaria malaria vaccine
GenPhar Marburg virus (DNA vaccine)
MedImmune parainfluenza virus infections in children and infants
MedImmune prevention of respiratory syncytial virus infections in infants
MedImmune prevention of parainfluenza virus infections in children and infants
MedImmune prevention of influenza virus (quadrivalent) for adolescents and children
sanofi pasteur Neisseria meningitidis A, C in toddlers 9 months-12 months
GlaxoSmithKline prevention of Neisseria meningitidis groups C and Y, Haemophilus influenzae type B, and tetanus toxoid
sanofi pasteur meningitis in infants
Novartis Vaccines meningococcal group B infections vaccine group B
Novartis Vaccines meningococcal group A, C infections in children
Novartis Vaccines meningococcal group A, C infections in infants
GlaxoSmithKline prevention of malaria (recombinant vaccine)
NanoBio prevention of influenza virus (intranasal)
GlaxoSmithKline prevention of influenza virus inactivated split-trivalent vaccine
GlaxoSmithKline prevention of Neisseria meningitidis groups A, C in children
LigoCyte Pharmaceuticals norovirus infections (intranasal)
Novartis Vaccines prevention of influenza virus
Protein Sciences prevention of influenza A pandemic (H5N1 subtype)
Meridian Biosciences parvovirus infections
Crucell prevention of influenza virus infections
Pfizer meningococcal group B infections (meningococcal “plague” vaccine)
DynPort Vaccine Yersinia infections (injectable)
Baxter Healthcare prevention of seasonal influenza virus
GlaxoSmithKline prevention of influenza A virus (“pre-pandemic”)
Pfizer prevention of pneumococcal infection in the elderly (Prevnar 13 Adult™)
sanofi pasteur rabies vaccine
BioSante Pharmaceuticals ricin poisoning (“biodefense” vaccine)
Soligenix ricin poisoning
sanofi pasteur prevention of rotavirus infections
Bharat Biotech prevention of rotavirus infections
Emergent BioSolutions anthrax (Fast Track) “protective antigen” vaccine
Inhibitex staphylococcal infections
Vical prevention of severe acute respiratory syndrome (SARS) coronavirus infections
Emergent BioSolutions shigella infections
GlaxoSmithKline prevention of herpes simplex virus infections
PharmAthene anthrax (“protective antigen” – rPA)
BioSante Pharmaceuticals staphylococcal infections (“biodefense” vaccine)
Nabi Biopharmaceutical prevention of staphylococcal aureus infections
GlaxoSmithKline prevention of staphylococcal aureus infections
Nabi Biopharmaceutical prevention of streptococcal B infections
Emergent BioSolutions prevention of streptococcal infections
Novartis Vaccines prevention of streptococcal infections
sanofi pasteur prevention of meningitis and pneumonia (tetravalent)
Inviragen treatment of dengue fever
Intercell USA prevention of traveler’s diarrhea due to E. coli (“patch” technology)
GlaxoSmithKline tuberculosis
Aerus Global TB prevention of tuberculosis in young children
GlaxoSmithKline prevention of tuberculosis in adults
sanofi pasteur prevention of tuberculosis
DynPort Vaccine tularemia
Emergent BioSolutions prevention of typhoid (live typhoid organisms – oral vaccine)
Novartis Vaccines prevention of typhoid fever
Celldex Therapeutics typhoid fever
Merck prevention of herpes zoster (shingles)
Merck hepatitis B in infants
Merck human papillomavirus infections
Merck staphylococcal infections
GlaxoSmithKline prevention of varicella zoster virus
VaxInnate prevention of influenza A virus
VaxInnate influenza A virus infections in elderly patients
VaxInnate prevention of influenza A virus (H1N1 subtype)
Inovio Pharmaceuticals human papillomavirus infections
Inovio Pharmaceuticals prevention of influenza A virus (H5N1 subtype)
Xcellerex prevention of yellow fever
Dr Gary G. Kohls is a
retired physician from Duluth, MN, USA. In the decade prior to his
retirement from medicine, he had spent the last decade practicing what
could best be described as “holistic (non-drug) mental health care”. Dr
Kohls has been actively involved in peace, justice and nonviolence
issues for much of his adult life and, since he retired, he has written a
weekly column for the Duluth Reader, an alternative newsweekly magazine
(www.readerduluth.com).
His columns mostly deal with the dangers of American fascism,
corporatism, militarism, racism, malnutrition, psychiatry and other
movements that threaten American democracy and civility.
This work is
reproduced and distributed with the permission and request
of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Click here http://www.greenmedinfo.com/greenmed/newsletter.”
We Need Your Support...
In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!
SUPPORT CE HERE!
No comments:
Post a Comment